Bone mineral density (BMD) T-score classification significantly underestimated risk of major osteoporotic fracture in the Women's Health Initiative (WHI) study, according to a new study.
Because all gynecological cancers are not the same, women surviving gynecological cancer should be able to access individualized therapies, according to the European Menopause and Andropause Society (EMAS) and the International Gynecologic Cancer Society (IGCS).
A pooled analysis of fall incidence showed that denosumab may reduce the risk of falls, as well as provide established fracture risk reduction, according a study published in the Journal of Bone and Mineral Research.
Vitamin D deficiency is significantly associated with lumbar disc degeneration and low back pain among postmenopausal women, according to research from Menopause.
Although both treatments increased lumbar spine bone mineral density (BMD) in a retrospective chart review, denosumab demonstrated a significantly greater effect.
For patients with osteoporosis, drug treatments with bisphosphonates may not reduce overall mortality rates, according to a meta-analysis from JAMA Internal Medicine.
Postmenopausal women who reported 5 hours or less of sleep per night had increased rates of low bone mineral density (BMD) and osteoporosis, according to research from JBMR.
New research from BMC Geriatrics reinforces the importance of pain management and exercise for osteoporotic patients.
The diagnostic capability of diffusion-weighted magnetic resonance imaging (DWI) to assess vertebral marrow changes in postmenopausal women with osteoporosis has been confirmed by a prospective study published in La radiologia medica and it may be a safer alternative to DEXA.
A prospective study published in Menopause has found that postmenopausal women who consume the equivalent of more than two 12-oz servings of soft drinks per day are at a significantly higher risk of hip fracture than postmenopausal women who drink less than one serving a day.